Fairvalue-Calculator Fairvalue-Calculator
EN DE

DHG Pharmaceutical Joint Stock Company (DHG) Fair Value & Analysis

Healthcare · VN · Market cap 12.2T VND

Price94,700 VND
Fair Value101,989 VND
Upside+7.7%
Quality95/100
Evidence: High Range 75,532 VND – 148,151 VND

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

DHG Pharmaceutical Joint Stock Company (DHG) currently trades at 94,700 VND, while our model-based Fair Value estimate is 101,989 VND — implying the stock looks roughly 7.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, dermatology, and beauty care products. It also manufactures and trades in health food, dietary and consumer health supplements, and pharmaceuticals cosmetic products. It also exports its products. DHG Pharmaceutical Joint Stock Company was founded in 1974 and is headquartered in Can Tho, Vietnam. DHG Pharmaceutical Joint Stock Company is a subsidiary of Taisho Pharmaceutical Co., Ltd.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% United Therapeutics Corporation (U2TH34) -73%

Frequently asked questions

Is DHG Pharmaceutical Joint Stock Company (DHG) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 101,989 VND versus a price of 94,700 VND — about +8% (undervalued). Model-based estimate, not financial advice.
What is the fair value of DHG?
Our 21-model fair value for DHG Pharmaceutical Joint Stock Company is 101,989 VND (as of Jun 24, 2026), built from audited fundamentals. The current price is 94,700 VND.
What is the quality score of DHG?
DHG Pharmaceutical Joint Stock Company has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.